Your browser doesn't support javascript.
loading
Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia.
Lee, Sung-Eun; Choi, Soo Young; Oh, Yun Jeong; Kim, Soo-Hyun; Song, Hye-Young; Yoo, Hea-Lyun; Lee, Mi-Young; Chae, Moon-Jung; Kang, Ki-Hoon; Hwang, Hee-Jeong; Jang, Eun-Jung; Kim, Dong-Wook.
Affiliation
  • Lee SE; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea; Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Choi SY; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Oh YJ; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Kim SH; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Song HY; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Yoo HL; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Lee MY; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Chae MJ; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Kang KH; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Hwang HJ; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Jang EJ; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Kim DW; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea; Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea. Electronic address: dwkim@catholic.ac.kr.
Leuk Res ; 39(4): 411-8, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25680524

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Biomarkers, Tumor / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Biomarkers, Tumor / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2015 Document type: Article